Harvard Bioscience Company Profile (NASDAQ:HBIO)

About Harvard Bioscience

Harvard Bioscience logoHarvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of specialized products, apparatus and scientific instruments. The Company's products are used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories across the world. The Company's core product range is organized into five product families: Fluidics, Lab Equipment and Supplies, Molecular Analysis, Cell Physiology and Animal Physiology. Its products include instruments, consumables, and systems that are made up of several individual products. The Company's brands include Harvard Apparatus, KD Scientific, Denville Scientific, AHN, Hoefer, Biochrom, BTX, Warner Instruments, MCS, HEKA, Hugo Sachs Elektronik, Panlab, Coulbourn Instruments, TBSI and CMA Microdialysis. The Company has sales and manufacturing operations in the United States, the United Kingdom, Germany, Sweden, Spain, France, Canada and China.

Industry, Sector and Symbol:
  • Sector: Computer and Technology
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: HBIO
  • CUSIP: 41690610
Key Metrics:
  • Previous Close: $2.88
  • 50 Day Moving Average: $2.67
  • 200 Day Moving Average: $2.96
  • 52-Week Range: $34,313,000.00 - $2.41
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 12.52
  • P/E Growth: 1.78
  • Market Cap: $98.82M
  • Outstanding Shares: 34,313,000
  • Beta: 0.95
Profitability:
  • Net Margins: -18.04%
  • Return on Equity: 3.40%
  • Return on Assets: 2.29%
Debt:
  • Debt-to-Equity Ratio: 0.18%
  • Current Ratio: 3.15%
  • Quick Ratio: 1.66%
Additional Links:
Companies Related to Harvard Bioscience:

Analyst Ratings

Consensus Ratings for Harvard Bioscience (NASDAQ:HBIO) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.00 (108.33% upside)

Analysts' Ratings History for Harvard Bioscience (NASDAQ:HBIO)
Show:
DateFirmActionRatingPrice TargetDetails
10/30/2015Benchmark Co.Lower Price TargetBuy$8.00 -> $6.00View Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for Harvard Bioscience (NASDAQ:HBIO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/27/2016        
7/28/2016Q2$0.03$0.03$26.60 million$26.10 millionViewListenView Earnings Details
5/12/2016Q1$0.02$0.05$26.00 million$27.00 millionViewListenView Earnings Details
4/29/2016Q4$0.03$0.03ViewN/AView Earnings Details
10/29/2015Q315$0.05$0.03$27.01 million$25.70 millionViewListenView Earnings Details
7/30/2015Q215$0.04$0.05$26.60 million$28.80 millionViewListenView Earnings Details
4/30/2015Q414$0.05$0.01$27.15 million$25.80 millionViewListenView Earnings Details
2/26/2015Q314$0.09$0.10$29.30 million$30.40 millionViewN/AView Earnings Details
10/30/2014Q214$0.06$0.06$25.46 million$25.40 millionViewN/AView Earnings Details
7/31/2014Q2$0.05$0.05ViewN/AView Earnings Details
5/1/2014Q114$0.03$0.05$26.10 million$25.90 millionViewN/AView Earnings Details
2/27/2014Q413($0.02)$0.05$28.20 million$27.90 millionViewN/AView Earnings Details
10/31/2013Q313$0.01$0.05$26.10 million$25.10 millionViewN/AView Earnings Details
5/2/2013Q1 2013$0.08$28.30 million$26.10 millionViewN/AView Earnings Details
11/1/2012Q312$0.08$26.40 million$26.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Harvard Bioscience (NASDAQ:HBIO)
Current Year EPS Consensus Estimate: $0.16 EPS
Next Year EPS Consensus Estimate: $0.23 EPS

Dividends

Dividend History for Harvard Bioscience (NASDAQ:HBIO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Harvard Bioscience (NASDAQ:HBIO)
Insider Ownership Percentage: 8.80%
Institutional Ownership Percentage: 66.31%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/10/2015Jeffrey DucheminCEOBuy10,000$3.37$33,700.00View SEC Filing  
12/3/2015George UvegesDirectorBuy3,000$3.32$9,960.00View SEC Filing  
11/9/2015Robert E GagnonCFOBuy3,000$3.08$9,240.00View SEC Filing  
9/2/2015Jeffrey DucheminCEOBuy2,000$4.41$8,820.00View SEC Filing  
9/1/2015John F KennedyDirectorBuy2,000$4.33$8,660.00View SEC Filing  
7/17/2015David GreenDirectorSell17,103$5.26$89,961.78View SEC Filing  
7/14/2015David GreenDirectorSell51,597$5.28$272,432.16View SEC Filing  
4/23/2015David GreenDirectorSell118,500$6.03$714,555.00View SEC Filing  
4/22/2015David GreenDirectorSell123,997$6.23$772,501.31View SEC Filing  
4/17/2015David GreenDirectorSell42,503$6.55$278,394.65View SEC Filing  
4/14/2015David GreenDirectorSell80,168$6.61$529,910.48View SEC Filing  
2/9/2015David GreenDirectorSell48,712$5.25$255,738.00View SEC Filing  
12/30/2014David GreenDirectorSell16,173$5.25$84,908.25View SEC Filing  
12/29/2014David GreenDirectorSell100,167$5.25$525,876.75View SEC Filing  
12/22/2014David GreenDirectorSell80,202$5.02$402,614.04View SEC Filing  
11/19/2014David GreenDirectorSell10,000$4.95$49,500.00View SEC Filing  
10/31/2014David GreenDirectorSell117,654$4.97$584,740.38View SEC Filing  
6/16/2014Robert E GagnonCFOBuy5,000$3.86$19,300.00View SEC Filing  
5/29/2014Neal J HarteDirectorSell12,317$3.82$47,050.94View SEC Filing  
4/9/2014David GreenDirectorSell27,540$4.47$123,103.80View SEC Filing  
4/8/2014David GreenDirectorSell66,090$4.48$296,083.20View SEC Filing  
4/3/2014David GreenDirectorSell63,501$4.63$294,009.63View SEC Filing  
8/27/2013Chane GrazianoMajor ShareholderBuy60,000$5.00$300,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Harvard Bioscience (NASDAQ:HBIO)
DateHeadline
capitalcube.com logoETF’s with exposure to Harvard Bioscience, Inc. : September 9, 2016 (NASDAQ:HBIO)
www.capitalcube.com - September 9 at 5:09 PM
finance.yahoo.com logoHarvard Bioscience (HBIO): Moving Average Crossover Alert (NASDAQ:HBIO)
finance.yahoo.com - August 29 at 5:16 PM
bizjournals.com logoEXCLUSIVE: UW president lays out vision for Global Innovation Exchange (NASDAQ:HBIO)
www.bizjournals.com - August 17 at 5:36 PM
capitalcube.com logoHarvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 (NASDAQ:HBIO)
www.capitalcube.com - August 11 at 5:38 PM
sg.finance.yahoo.com logoHarvard Bioscience reports 2Q loss (NASDAQ:HBIO)
sg.finance.yahoo.com - July 28 at 10:42 AM
finance.yahoo.com logo7:30 am Harvard Bioscience reports Q2; guides FY16 (NASDAQ:HBIO)
finance.yahoo.com - July 28 at 7:30 AM
capitalcube.com logoETF’s with exposure to Harvard Bioscience, Inc. : July 21, 2016 (NASDAQ:HBIO)
www.capitalcube.com - July 21 at 2:06 PM
4-traders.com logoHARVARD BIOSCIENCE SCHEDULES SECOND QUARTER 2016 CONFERENCE CALL FOR JULY 28 AT 8 : 30 am et (NASDAQ:HBIO)
www.4-traders.com - July 18 at 5:34 PM
finance.yahoo.com logoHarvard Bioscience Schedules Second Quarter 2016 Conference Call for July 28 at 8:30 AM ET (NASDAQ:HBIO)
finance.yahoo.com - July 18 at 4:30 PM
capitalcube.com logoETF’s with exposure to Harvard Bioscience, Inc. : July 1, 2016 (NASDAQ:HBIO)
www.capitalcube.com - July 1 at 6:17 PM
biz.yahoo.com logoHARVARD BIOSCIENCE INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:HBIO)
biz.yahoo.com - June 27 at 4:16 PM
News IconBroker Watchlist: Harvard Bioscience, Inc. (HBIO) - Share Trading News (NASDAQ:HBIO)
www.sharetrading.news - June 2 at 8:07 AM
publicnow.com logoHarvard Bioscience to Attend The Benchmark Company, LLC One-on-One Conference in Milwaukee, Wisconsin on June 2, 2016 (NASDAQ:HBIO)
www.publicnow.com - May 31 at 6:42 AM
News IconNext Weeks Broker Price Targets For Harvard Bioscience, Inc. (HBIO) - Share Trading News (NASDAQ:HBIO)
www.sharetrading.news - May 30 at 9:58 PM
News IconPerformance at a Glance on Harvard Bioscience Inc. (NASDAQ:HBIO) - HNN (NASDAQ:HBIO)
hintsnewsnetwork.com - May 29 at 1:52 PM
biz.yahoo.com logoHARVARD BIOSCIENCE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi (NASDAQ:HBIO)
biz.yahoo.com - May 27 at 4:11 PM
capitalcube.com logoHarvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:HBIO)
www.capitalcube.com - May 13 at 12:16 PM
finance.yahoo.com logoEdited Transcript of HBIO earnings conference call or presentation 12-May-16 12:30pm GMT (NASDAQ:HBIO)
finance.yahoo.com - May 12 at 10:50 AM
biz.yahoo.com logoQ4 2015 and Q1 2016 Harvard Bioscience Inc Earnings Call scheduled for 8:30 am ET today (NASDAQ:HBIO)
biz.yahoo.com - May 12 at 8:30 AM
biz.yahoo.com logoQ1 2016 Harvard Bioscience Inc Earnings Release - Before Market Open (NASDAQ:HBIO)
biz.yahoo.com - May 12 at 7:07 AM
publicnow.com logoHarvard Bioscience Reports First Quarter 2016 Financial Results (NASDAQ:HBIO)
www.publicnow.com - May 12 at 6:27 AM
biz.yahoo.com logoHARVARD BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex (NASDAQ:HBIO)
biz.yahoo.com - May 12 at 6:24 AM
sg.finance.yahoo.com logoHarvard Bioscience reports 1Q loss (NASDAQ:HBIO)
sg.finance.yahoo.com - May 12 at 6:15 AM
publicnow.com logoHarvard Bioscience Regains Compliance with NASDAQ's Continued Listing Requirements (NASDAQ:HBIO)
www.publicnow.com - May 4 at 4:20 PM
finance.yahoo.com logoHarvard Bioscience Regains Compliance with NASDAQ’s Continued Listing Requirements (NASDAQ:HBIO)
finance.yahoo.com - May 4 at 4:15 PM
thestreet.com logoHarvard Bioscience Reports Fourth Quarter And Year-End 2015 Results, Preliminary First Quarter 2016 Revenues And 2016 Financial Guidance (NASDAQ:HBIO)
www.thestreet.com - April 29 at 5:42 PM
sg.finance.yahoo.com logoHarvard Bioscience reports 4Q loss (NASDAQ:HBIO)
sg.finance.yahoo.com - April 29 at 5:07 PM
seekingalpha.com logoHarvard Bioscience to delay 10-K filing, reports Preliminary Q4 revenue (NASDAQ:HBIO)
seekingalpha.com - March 28 at 6:55 PM
News IconHarvard Bioscience: 1 Analysts Continue to rate NASDAQ:HBIO - Hints News Network (NASDAQ:HBIO)
hintsnewsnetwork.com - February 26 at 1:00 PM
News IconCould Harvard Bioscience, Inc. Rise Even More? The Stock Had Another Big Increase Today - RiversideGazette.com (NASDAQ:HBIO)
www.riversidegazette.com - February 26 at 1:00 PM
News IconEarnings Per Share Preview for Harvard Bioscience, Inc. (HBIO) - RiversideGazette.com (NASDAQ:HBIO)
www.riversidegazette.com - February 26 at 1:00 PM
News IconWhy Heartland Advisors Inc Reported Big Harvard Bioscience Inc Position? - fdanewsalert.com (NASDAQ:HBIO)
www.fdanewsalert.com - February 5 at 2:42 PM
News IconRecent Broker Updates On Harvard Bioscience, Inc. (HBIO) - Risers & Fallers (NASDAQ:HBIO)
www.risersandfallers.com - February 3 at 2:04 PM
News IconLatest Analysts Reports On Harvard Bioscience, Inc. (HBIO) - Risers & Fallers (NASDAQ:HBIO)
www.risersandfallers.com - January 26 at 2:01 PM
finance.yahoo.com logoHARVARD BIOSCIENCE INC Financials (NASDAQ:HBIO)
finance.yahoo.com - December 8 at 1:17 PM
finance.yahoo.com logoFalling Earnings Estimates Signal Weakness Ahead for Harvard Bioscience (HBIO) (NASDAQ:HBIO)
finance.yahoo.com - November 25 at 8:31 AM
finance.yahoo.com logoStrong Revenue Growth in the $6 Billion Biological Sample Preparation Market (NASDAQ:HBIO)
finance.yahoo.com - November 13 at 9:20 AM
biz.yahoo.com logoHARVARD BIOSCIENCE INC Files SEC form 10-Q, Quarterly Report (NASDAQ:HBIO)
biz.yahoo.com - November 5 at 5:58 PM
finance.yahoo.com logoEdited Transcript of HBIO earnings conference call or presentation 29-Oct-15 12:30pm GMT (NASDAQ:HBIO)
finance.yahoo.com - October 29 at 9:58 AM
biz.yahoo.com logoHarvard Bioscience Inc Earnings Call scheduled for 8:30 am ET today (NASDAQ:HBIO)
biz.yahoo.com - October 29 at 8:30 AM
biz.yahoo.com logoHARVARD BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Costs Associated with Exit (NASDAQ:HBIO)
biz.yahoo.com - October 29 at 7:17 AM
biz.yahoo.com logoQ3 2015 Harvard Bioscience Inc Earnings Release - Before Market Open (NASDAQ:HBIO)
biz.yahoo.com - October 29 at 7:07 AM
sg.finance.yahoo.com logoHarvard Bioscience reports 3Q loss (NASDAQ:HBIO)
sg.finance.yahoo.com - October 29 at 7:03 AM
noodls.com logoHarvard Bioscience Reports Third Quarter 2015 Financial Results and Updates Outlook for Full-Year 2015 (NASDAQ:HBIO)
www.noodls.com - October 29 at 6:58 AM

Social

Harvard Bioscience (NASDAQ:HBIO) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff